NEW YORK, May 29, 2014 /PRNewswire/ -- Genpact Limited (NYSE: G), a global leader in transforming and running business processes and operations, has closed its previously announced acquisition of Pharmalink Consulting. Now part of Genpact's growing life sciences vertical, the new business is named Genpact Pharmalink Global Regulatory Affairs.
Genpact Pharmalink Global Regulatory Affairs combines Pharmalink's specialized domain expertise in consulting, project support and outsourced regulatory affairs services with Genpact's global delivery, BPO, technology and analytics offerings for the life sciences market. Genpact's expanded capabilities now support core life sciences R&D functions such as regulatory strategy, filings, complex compliance services, patient safety and management of post-licensing activities.
"Genpact is thrilled to add this extremely talented group of life sciences experts to our growing operations," said Balkrishan 'BK' Kalra, senior vice president and business leader, Life Sciences, Genpact. "We are confident that Genpact Pharmalink Global Regulatory Affairs will transform the way life sciences companies address the ongoing and complex challenges in the area of regulatory affairs."
"With significant cultural synergies that have been evident from the outset, our team across the US, UK, India, Ireland and Puerto Rico is excited to be officially part of Genpact," said Kevin Webb, chief operating officer, Genpact Pharmalink Global Regulatory Affairs. "We are already developing a next generation offering to meet growing needs within a rapidly-changing market."
Genpact Limited (NYSE: G) is a global leader in transforming and running business processes and operations, including those that are complex and industry-specific. Our mission is to help clients become more competitive by making their enterprises more intelligent through becoming more adaptive, innovative, globally effective and connected to their own clients. Genpact stands for Generating Impact – visible in tighter cost management as well as better management of risk, regulations and growth for hundreds of long-term clients including more than 100 of the Fortune Global 500. Our approach is distinctive – we offer an unbiased, agile combination of smarter processes, crystallized in our Smart Enterprise Processes (SEPSM) proprietary framework, along with analytics and technology, which limits upfront investments and enhances future adaptability. We have global critical mass – 64,000+ employees in 24 countries with key management and corporate offices in New York City – while remaining flexible and collaborative, and a management team that drives client partnerships personally. Our history is unique – behind our single-minded passion for process and operational excellence is the Lean and Six Sigma heritage of a former General Electric division that has served GE businesses for more than 15 years. For more information, visit www.genpact.com.
For more information:
SOURCE Genpact Limited